Les tumeurs de la sphere ORL: standards de traitement et nouvelles approches en radiothérapie.

Coucke, Philippe; Piret, Pascal; Werenne, Xavier; Demez, Pierre; Sautois, Brieuc; Moreau, Pierre

Download

Article (Scientific journals)

Les tumeurs de la sphere ORL: standards de traitement et nouvelles approches en radiothérapie.

Coucke, Philippe; Piret, Pascal; Werenne, Xavier et al.

2008 • In Revue Médicale de Liège, 63 (3), p. 141-8

Peer reviewed

Permalink
https://hdl.handle.net/2268/8922

PubMed
18561770

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Les tumeurs de la sphere ORL standards de traitement et nouvelles approches en radiotherapie..pdf

Publisher postprint (457.25 kB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Combined Modality Therapy; Head and Neck Neoplasms/mortality/therapy; Humans

Abstract :

[en] We intend to review the general value of radiotherapy in the management of head and neck cancer. Our aim is to define a treatment protocol which is evidence-based and therefore of use in daily clinical practice. There is general agreement on the efficacy of the concomitant schedules combining radiotherapy and chemotherapy, both in the adjuvant setting as well as in the exclusive non-surgical approach. This however does not preclude further research aiming at optimizing the therapeutic index. As far as neoadjuvant chemotherapy is concerned, applied prior to radical local treatment, there are no conclusive data available which allows us to implement this treatment option in routine clinical practice. This approach deserves further investigations and patients should be entered in well designed prospective randomized trials.

Disciplines :

Oncology

Author, co-author :

Coucke, Philippe ; Centre Hospitalier Universitaire de Liège - CHU > Radiothérapie

Piret, Pascal ; Centre Hospitalier Universitaire de Liège - CHU > Radiothérapie

Werenne, Xavier ; Centre Hospitalier Universitaire de Liège - CHU > Radiothérapie

Demez, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > O.R.L.

Sautois, Brieuc ; Centre Hospitalier Universitaire de Liège - CHU > Oncologie médicale

Moreau, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > O.R.L.

Language :

French

Title :

Les tumeurs de la sphere ORL: standards de traitement et nouvelles approches en radiothérapie.

Alternative titles :

[en] Head and neck tumors: standards of care and new approaches

Publication date :

2008

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Hopital de Baviere, Liège, Belgium

Volume :

Issue :

Pages :

141-8

Peer reviewed :

Peer reviewed

Available on ORBi :

since 21 March 2010

Statistics

Number of views

98 (3 by ULiège)

Number of downloads

169 (3 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenAlex citations

Bibliography

Bernier J, Domenge C, Ozsahin M, et al. - Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med, 2004, 350, 1945-1952.
Cooper JS, Pajak TF, Forastière AA, et al. - Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous -cell carcinoma of the head and neck. N Engl J Med, 2004, 350, 1937-1944.
Ang KK, Trotti A, Brown BW, et al. - Randomized trials addressing risk features and time factors of surgery plus radiotherapy in advanced head and neck cancer. Int J Radiat Oncol Biol Phys, 2001, 51, 571-578.
Bernier J, Vermorken JB, Koch WM. - Adjuvant therapy in patients with resected poor-risk head and neck cancer. J Clin Oncol, 2006, 24, 2629-2635.
Rosenthal DI, Liu L, Jee JH, et al. - Importance of treatment package time in surgery and postoperative radiation therapy for squamous cell carcinoma of the head and neck. Head Neck, 2002, 24, 115-126.
Bourrhis J, Overgaard J, Audry H, et al. - Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet,2006, 368, 843-854.
Budach W, Hehr T, Budach V, et al. - A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally adavanced squamous cell carcinoma of the head and neck. BMC Cancer, 2006, 6, 1-12.
Fowler JF, Harari PM. - Confirmation of improved local-regional control with altered fractionation in head and neck cancer. Int J Radiat Oncol Biol Phys, 2000, 48, 3-6.
Denham JW, Peters LJ, Johansen J, et al. - Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer? Radiother Oncol, 1999, 52, 157-164.
Bolle S, Louis C, Coucke PA. - Innovations technologiques en radiothérapie-oncologie. Rev Med Liege, 2007, 62, 399-404.
Andreassen CN, Grau C, Lindegaard JC. - Chemical radioprotection: a critical review of amifostine as a cytoprotector in radiotherapy. Semin Radiat Oncol, 2003, 13, 62-72.
Bourhis J, Thepamongkhol K, Pignon JP. - Randomized trials of amifostine and radiotherapy : effect on survival? Semin Oncol, 31, 62-66.
Pignon JP, Bourhis J, Domenge C, Designé L, on behalf of the MACH-NC Collaborative Group. - Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: three meta-analyses of updated individual data. Lancet, 2000, 355, 949-955.
Pignon JP, Baujat B, Bourhis J, et al. - Individual patient data meta-analyses in head and neck carcinoma: what have we learnt? Cancer Radiother, 2005, 9, 31-36.
Eschwege F, Sancho-Garnier H, Gerard JP, et al. - Ten-year results of randomized trial comparing radiotherapy and concomitant bleomycin to radiotherapy alone in epidermoid carcinomas of the oropharynx: experience of the European Organization for Research and Treatment of Cancer. NCI Monogr, 1988, 6, 275-278.
Salvajoli JV, Morioka H, Trippe N, et al. - A randomized trial of neoadjuvant vs concomitant chemotherapy vs radiotherapy alone in the treatment of stage IV head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol, 1992, 249, 211-215.
Zakotnik B, Smid L, Budihna M, et al. - Concomitant radiotherapy with mitomycin C and bleomycin compared with radiotherapy alone in inoperable head and neck cancer: final report. Int J Radiat Oncol Biol Phys, 1998, 41, 1121-1127.
Brizel DM, Esclamado R. - Concurrent chemoradiotherapy for locally advanced, nonmetastatic, squamous carcinoma of the head and neck : consensus, controversy and conundrum. J Clin Oncol, 2006, 24, 2612-2617.
Bernier J, Bentzen SM. - Altered fractionation and combined radio-chemotherapy approaches: pioneering new opportunities in head and neck oncology. Eur J Can, 2003, 39, 560-571.
Staar S, Rudat V, Stuetzer H, et al. - Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy - results of a multicentric randomized german trial in advanced head and neck cancer. Int J Radiat Oncol Biol Phys, 2001, 50, 1161-1171.
Domenge C, Hill C, Lefebvre JL, et al. - Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tête et du Cou (GETTEC). Br J Cancer, 2000, 83, 1594-1598.
Zorat PL, Paccagnella A, Cavaniglia, et al. - Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer. 10-year follow-up. J Natl Cancer Inst, 2004, 96, 1714-1717.
Pfister DG, Ridge JA. - Induction chemotherapy for larynx preservation : patient selection or therapeutic effect? J Clin Oncol, 2006, 24, 540-543.
Posner MR, Hesshock DM, Blajman CR, et al. - Cisplatin and fluoro-uracil alone or with docetaxel in head and neck cancer. N. Engl. J. Med, 2007, 357, 1705-1715.
Vermorken JM, Remenor E, von Herpen C, et al. - Ciplastin, fluoro-uracil and docetaxel in unresectable head ans neck cancer. N. Engl. J. Med, 2007, 357, 1695-1704.
Adelstein DJ, LeBlanc M. - Does induction chemotherapy have a role in the management of loco regionally advanced squamous cell head and neck cancer. J Clin Oncol, 24, 2624-2627.
Bonner JA, Harari PM, Giralt J, et al. - Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med, 2006, 354, 567-578.
Eriksen JG, Steiniche T, Overgaard J, et al. - The influence of epidermal growth factor receptor and tumor differentiation on the response to accelerated radiotherapy of squamous cell carcinomas of the head and neck in the randomized DAHANCA 6 and 7 study. Radiother Oncol, 2005, 74, 93-100.
Posner MR, Wirth LJ. - Cetuximab and radiotherapy for head and neck cancer. N Engl J Med, 2006, 354, 634-636.
Burtness B, Goldwasser MA, Flood W, et al. - Phase III randomized trial of cisplatine plus placebo compared with cisplatine plus cetuximab in metastatic / recurrent head and neck cancer: an eastern cooperative oncology group study. J Clin Oncol, 2005, 23, 8646-8654.